ABSTRACT
Spontaneous epistaxis in patients with COVID-19 can represent a clinical challenge with respect to both the risk of contamination and the treatment options. We herein present the data of 30 patients with COVID-19 who developed spontaneous epistaxis while hospitalized at Eastern Piedmont Hospital during March and April 2020. All patients received low-molecular-weight heparin during their hospital stay and required supplementary oxygen therapy either by a nasal cannula or continuous positive airway pressure. Both conditions can represent risk factors for developing epistaxis. Prevention of crust formation in patients with rhinitis using a nasal lubricant should be recommended. If any treatment is required, appropriate self-protection is mandatory.
Subject(s)
Coronavirus Infections/pathology , Epistaxis/pathology , Oxygen Inhalation Therapy/methods , Pneumonia, Viral/pathology , Aged , Betacoronavirus , COVID-19 , Cannula , Continuous Positive Airway Pressure , Epistaxis/virology , Female , Heparin/adverse effects , Humans , Male , Middle Aged , Nasal Mucosa/injuries , Pandemics , SARS-CoV-2ABSTRACT
OBJECTIVE: To evaluate the prevalence of severe acute respiratory syndrome coronavirus-2 infection in patients presenting with epistaxis to a tertiary otolaryngology unit. METHODS: A prospective study was conducted of 40 consecutive patients presenting with epistaxis referred to our tertiary otolaryngology unit. A group of 40 age-matched controls were also included. All patients underwent real-time reverse transcriptase polymerase chain reaction testing for severe acute respiratory syndrome coronavirus-2. Symptoms of fever, cough and anosmia were noted in the study group. RESULTS: The mean age was 66.5 ± 22.4 years in the study group. There were 22 males (55 per cent) and 18 females (45 per cent). The mean age in the control group was 66.3 ± 22.4 years (p = 0.935). There were six positive cases for severe acute respiratory syndrome coronavirus-2 (15 per cent) in the epistaxis group and one case (2.5 per cent) in the control group. The difference was statistically significant (p = 0.05). CONCLUSION: Epistaxis may represent a presenting symptom of severe acute respiratory syndrome coronavirus-2 infection. This may serve as a useful additional criterion for screening patients.
Subject(s)
Betacoronavirus/genetics , Coronavirus Infections/complications , Coronavirus Infections/epidemiology , Epistaxis/diagnosis , Pneumonia, Viral/complications , Pneumonia, Viral/epidemiology , Adult , Aged , Aged, 80 and over , Betacoronavirus/isolation & purification , COVID-19 , Case-Control Studies , Coronavirus Infections/drug therapy , Coronavirus Infections/virology , Cough/diagnosis , Cough/virology , Epistaxis/epidemiology , Epistaxis/virology , Female , Fever/diagnosis , Fever/virology , Humans , Male , Middle Aged , Olfaction Disorders/diagnosis , Olfaction Disorders/virology , Otolaryngology/standards , Pandemics , Pneumonia, Viral/drug therapy , Pneumonia, Viral/virology , Prevalence , Prospective Studies , Real-Time Polymerase Chain Reaction , SARS-CoV-2 , Tertiary Care Centers/standards , United Kingdom/epidemiologyABSTRACT
Infectious mononucleosis, caused by the Epstein-Barr virus (EBV), generally follows a benign, yet protracted course, with the majority of symptoms being systemic somatic symptoms. Rarely, the clinical picture can be complicated by more acute severe haemotological sequelae of the disease, requiring hospitalisation and causing diagnostic uncertainty, particularly when distinguishing between a viral illness and a lymphoproliferative disorder. We describe the case of a young male patient who presented with headache, recurrent epistaxis and severe thrombocytopenia.
Subject(s)
Epistaxis/virology , Epstein-Barr Virus Infections/blood , Infectious Mononucleosis/blood , Infectious Mononucleosis/virology , Thrombocytopenia/virology , Adult , Diagnosis, Differential , Epistaxis/pathology , Epstein-Barr Virus Infections/pathology , Herpesvirus 4, Human/isolation & purification , Humans , Male , Polymerase Chain Reaction/methods , Recurrence , Thrombocytopenia/pathologyABSTRACT
BACKGROUND: Hepatitis C virus (HCV) affects extra-hepatic organs, but its effect on the nose is poorly defined. OBJECTIVES: To investigate the histological changes in nasal tissue induced by HCV and whether the nasal mucosa harbors the virus for extrahepatic replication. STUDY DESIGN: We investigated nasal biopsies from 20 patients with HCV infection, and from 10 control subjects. All biopsies were subjected to real time polymerase chain reaction (RT-PCR) as well as histology. RESULTS: Our analyses showed that 60% of HCV positive samples showed nasal epithelial erosion, 95% showed subepithelial non-specific inflammation and/or fibrosis, while only 5% showed normal histology. However, none of the twenty PCR samples showed the presence of HCV nucleic acids sequences in the nasal tissues. On the other hand, all control subjects had normal histology and the absence of the viral m-RNA in the PCR (100%). CONCLUSIONS: HCV induces histopathological rhinitis with nasal epithelial erosion. However, it does not seem that the nasal tissue harbors the virus.
Subject(s)
Hepacivirus/isolation & purification , Nasal Mucosa/pathology , Nasal Mucosa/virology , Rhinitis/virology , Adult , Aged , Epistaxis/virology , Female , Humans , Liver Function Tests , Male , Middle Aged , Polymerase Chain Reaction , RNA, Viral/isolation & purification , Young AdultABSTRACT
Epstein-Barr viral (EBV)-infection usually presents as fever, sore throat, fatigue, lymphadenopathy and atypical lymphocytosis. We describe a patient with disseminated intravascular coagulation as the presenting symptom caused by a primary EBV infection.
